Intervention

Netarsudil 0.02% Ophthalmic Solution

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

2 shown

The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal DystrophyNCT06969586 · 2025-04-01

ENROLLING_BY_INVITATION

Next Generation RocklatanNCT06441643 · 2024-09-04

Common conditions

Cataract1 Fuchs Endothelial Corneal Dystrophy1 Glaucoma1 Ocular Hypertension1 Open Angle Glaucoma1

Leading sponsors

Alcon Research1 University Hospital Dubrava1

Trial status mix

COMPLETED1

ENROLLING_BY_INVITATION1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.